Ipsen
Ipsen S.A. is a global biopharmaceutical group focused on innovation and specialty healthcare. The company operates primarily in the fields of oncology, neurology, and rare diseases, developing and manufacturing a range of products including drugs and biologics. Ipsen's core products include treatments for various cancers, such as Somatuline for neuroendocrine tumors, and Dysport for neurological disorders. With a strong commitment to research and development, Ipsen strives to improve patient outcomes through advanced therapies and personalized medicine.